Corruption Index 2025 Flags Global Governance Risks
BERLIN, Germany, Feb. 10, 2026 — The release of the Corruption Perceptions Index (CPI) 2025 by Transparency International has...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
BERLIN, Germany, Feb. 10, 2026 — The release of the Corruption Perceptions Index (CPI) 2025 by Transparency International has...
Santa Ana, California, December 3, 2025 — NKGen Biotech has issued an official statement regarding new board appointments at...
MELBOURNE, Australia – Nov. 26, 2025 — Neurizon Therapeutics (ASX: NUZ & NUZOA; OTCQB: NUZTF), a clinical-stage biotech firm...
Dateline: November 14, 2025 — Bagsværd, DenmarkNovo Nordisk A/S announced a series of major Board of Directors changes following...
